Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Gan & Lee Pharmaceutical
Explore 16 clinical trials worldwide
Search
Showing 1-16 of 16 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Gan & Lee Pharmaceutical
Clinical Trials (16)
NCT07128888
Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection
PHASE1
Not yet recruiting
60 participants
Started: Nov 17, 2025 · Completed: Jul 5, 2026
1 condition
1 sponsor
1 location
NCT07193147
Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment
PHASE1
Not yet recruiting
36 participants
Started: Oct 13, 2025 · Completed: Nov 4, 2026
1 condition
1 sponsor
1 location
NCT07165223
A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
PHASE3
Not yet recruiting
300 participants
Started: Sep 28, 2025 · Completed: Nov 10, 2026
1 condition
1 sponsor
1 location
NCT07150975
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
PHASE3
Not yet recruiting
420 participants
Started: Sep 15, 2025 · Completed: Jun 30, 2027
1 condition
1 sponsor
0 locations
NCT07144098
Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Function
PHASE1
Recruiting
24 participants
Started: Aug 12, 2025 · Completed: Jan 26, 2027
1 condition
1 sponsor
1 location
NCT07055386
A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus
PHASE2
Active, not recruiting
90 participants
Started: Jun 24, 2025 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT06974487
A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects
PHASE1
Not yet recruiting
30 participants
Started: May 8, 2025 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT07119450
The Study of [14C] GZR18
PHASE1
Active, not recruiting
6 participants
Started: May 7, 2025 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT07141030
Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Function
PHASE1
Recruiting
32 participants
Started: Apr 11, 2025 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06767748
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
PHASE3
Recruiting
620 participants
Started: Feb 17, 2025 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT06767761
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated with Basal + Prandial Insulin
PHASE3
Not yet recruiting
580 participants
Started: Feb 14, 2025 · Completed: Apr 9, 2026
1 condition
1 sponsor
0 locations
NCT06767735
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects with Type 2 Diabetes Mellitus (T2DM)
PHASE3
Not yet recruiting
580 participants
Started: Feb 14, 2025 · Completed: Aug 17, 2026
1 condition
1 sponsor
0 locations
NCT06777238
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects with Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise
PHASE3
Not yet recruiting
270 participants
Started: Jan 17, 2025 · Completed: Mar 10, 2027
1 condition
1 sponsor
0 locations
NCT06778967
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
PHASE3
Not yet recruiting
1,100 participants
Started: Jan 7, 2025 · Completed: Dec 11, 2026
1 condition
1 sponsor
0 locations
NCT06728124
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects
PHASE3
Not yet recruiting
630 participants
Started: Dec 31, 2024 · Completed: May 31, 2026
1 condition
1 sponsor
0 locations
NCT06780410
A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
PHASE3
Recruiting
240 participants
Started: Dec 20, 2024 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location